5 completed, 1 recruiting, 1 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 5, Recruiting 1, Unknown 1 |
Follow Cardiac Output, Low: new trials by email Literature Review of Cardiac Output, Low trials Research Report on Cardiac Output, Low
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Landiolol in Mitral Valve Surgery Landiolol, Placebo - Cardiac Failure, Low Cardiac Output Syndrome | Phase 4 | Recruiting | Università Vita-Salute San Raffaele | 1500 | 2025-01-28 | 2025-12-29 |
| The Effect of Epinephrine, Norepinephrine and Phenylephrine on Intraoperative Hemodynamic Performance Epinephrin, Norepinephrine, Phenylephrine - Cardiac Output, Low, Cardiac Output, High | Phase 4 | Unknown | Medical University of Vienna | 225 | 2022-09-01 | 2022-10-19 |
| Methoxyflurane and Fentanyl in LBNP Lower body negative pressure (LBNP) - Hypovolemia, Cardiac Output, Low | Phase 4 | Completed | Oslo University Hospital | 15 | 2020-11-18 | 2022-06-30 |
| Milrinone Versus Dobutamine in Critically Ill Patients Milrinone, Dobutamine - Low Cardiac Output Syndrome, Cardiogenic Shock | Phase 4 | Completed | Ottawa Heart Institute Research Corporation | 192 | 2017-08-30 | 2020-06-30 |
| Cardiac Index Changes With Ephedrine, Phenylephrine, Ondansetron and Norepinephrine During Spinal Anesthesia cardiac output changes with "ephedrine", cardiac output changes with "phenylephrine", cardiac output changes with "ondansetron" - Cardiac Output, Low | Phase 4 | Completed | University Tunis El Manar | 120 | 2017-02-23 | 2018-08-29 |
| Levosimendan in High Risk Patients Undergoing Cardiac Surgery Levosimendan, placebo - Low Cardiac Output Syndrome | Phase 4 | Completed | Università Vita-Salute San Raffaele | 1000 | 2009-11-01 | 2016-07-22 |
| Losartan in Decompensated Heart Failure Losartan, Placebo - Congestive Heart Failure, Low Cardiac Output | Phase 4 | Completed | InCor Heart Institute | 21 | 2008-09-01 | 2013-05-20 |
Heart Failure (2) · Acute Coronary Syndrome (1) · Agnosia (1) · Aneurysm (1) · Cardiac Output, High (1) · Hypovolemia (1) · Pulmonary Edema (1) · Shock, Cardiogenic (1)
Cardiovascular Diseases (7) · Heart Diseases (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Pathologic Processes (2) · Vascular Diseases (2) · Infarction (1) · Ischemia (1) · Lung Diseases (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Necrosis (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1)
Phenylephrine (2) · Cardiac Output (1) · Dobutamine (1) · Ephedrine (1) · Epinephrine (1) · Losartan (1) · Lower Body Negative Pressure (1) · Milrinone (1) · N(1)-methyl-2-lysergic acid diethylamide (1) · Norepinephrine (1) · Ondansetron (1) · Simendan (1) · landiolol (1)
Università Vita-Salute San Raffaele (2) · InCor Heart Institute (1) · Medical University of Vienna (1) · Oslo University Hospital (1) · Ottawa Heart Institute Research Corporation (1) · University Tunis El Manar (1)
Brazil (2) · Italy (2) · Austria (1) · Canada (1) · Norway (1) · Russia (1) · Tunisia (1)
Alberto Zangrillo, MD (1) · Antonio P Barretto, Ph.D. (1) · Benjamin M Hibbert, MD, PhD (1)
PMID 24838894, PMID 28320259, PMID 32402931, PMID 34347952, PMID 34376218, PMID 34713704, PMID 35261289, PMID 37638077